Hernandez Arturo, Martinez M Elena, Liao Xiao-Hui, Van Sande Jacqueline, Refetoff Samuel, Galton Valerie Anne, St Germain Donald L
Dartmouth Medical School, Lebanon, NH 03756, USA.
Endocrinology. 2007 Dec;148(12):5680-7. doi: 10.1210/en.2007-0652. Epub 2007 Sep 6.
The type 3 deiodinase (D3) is a selenoenzyme that inactivates thyroid hormones and is highly expressed during development and in the adult central nervous system. We have recently observed that mice lacking D3 activity (D3KO mice) develop perinatal thyrotoxicosis followed in adulthood by a pattern of hormonal levels that is suggestive of central hypothyroidism. In this report we describe the results of additional studies designed to investigate the regulation of the thyroid axis in this unique animal model. Our results demonstrate that the thyroid and pituitary glands of D3KO mice do not respond appropriately to TSH and TRH stimulation, respectively. Furthermore, after induction of severe hypothyroidism by antithyroid treatment, the rise in serum TSH in D3KO mice is only 15% of that observed in wild-type mice. In addition, D3KO animals rendered severely hypothyroid fail to show the expected increase in prepro-TRH mRNA in the paraventricular nucleus of the hypothalamus. Finally, treatment with T(3) results in a serum T(3) level in D3KO mice that is much higher than that in wild-type mice. This is accompanied by significant weight loss and lethality in mutant animals. In conclusion, the absence of D3 activity results in impaired clearance of T(3) and significant defects in the mechanisms regulating the thyroid axis at all levels: hypothalamus, pituitary, and thyroid.
3型脱碘酶(D3)是一种硒酶,可使甲状腺激素失活,在发育过程中和成年中枢神经系统中高度表达。我们最近观察到,缺乏D3活性的小鼠(D3基因敲除小鼠)在围产期会发生甲状腺毒症,成年后激素水平模式提示中枢性甲状腺功能减退。在本报告中,我们描述了旨在研究这种独特动物模型中甲状腺轴调节的其他研究结果。我们的结果表明,D3基因敲除小鼠的甲状腺和垂体分别对促甲状腺激素(TSH)和促甲状腺激素释放激素(TRH)刺激反应不当。此外,在通过抗甲状腺治疗诱导严重甲状腺功能减退后,D3基因敲除小鼠血清TSH的升高仅为野生型小鼠的15%。此外,严重甲状腺功能减退的D3基因敲除动物下丘脑室旁核中前促甲状腺激素释放激素(prepro-TRH)mRNA未出现预期增加。最后,用T3治疗导致D3基因敲除小鼠血清T3水平远高于野生型小鼠。这伴随着突变动物的显著体重减轻和死亡。总之,D3活性的缺失导致T3清除受损,以及在甲状腺轴调节机制的所有水平(下丘脑、垂体和甲状腺)出现显著缺陷。